Bausch Health Cos Common Stock Net 2010-2024 | BHC
Bausch Health Cos common stock net from 2010 to 2024. Common stock net can be defined as the value of common equity ownership.
Bausch Health Cos Annual Common Stock Net (Millions of US $) |
2023 |
$10,423 |
2022 |
$10,391 |
2021 |
$10,317 |
2020 |
$10,227 |
2019 |
$10,172 |
2018 |
$10,121 |
2017 |
$10,090 |
2016 |
$10,038 |
2015 |
$9,897 |
2014 |
$8,349 |
2013 |
$8,301 |
2012 |
$5,941 |
2011 |
$5,964 |
2010 |
$5,252 |
2009 |
$1,465 |
Bausch Health Cos Quarterly Common Stock Net (Millions of US $) |
2024-09-30 |
$10,489 |
2024-06-30 |
$10,483 |
2024-03-31 |
$10,480 |
2023-12-31 |
$10,423 |
2023-09-30 |
$10,420 |
2023-06-30 |
$10,412 |
2023-03-31 |
$10,405 |
2022-12-31 |
$10,391 |
2022-09-30 |
$10,387 |
2022-06-30 |
$10,380 |
2022-03-31 |
$10,373 |
2021-12-31 |
$10,317 |
2021-09-30 |
$10,312 |
2021-06-30 |
$10,300 |
2021-03-31 |
$10,289 |
2020-12-31 |
$10,227 |
2020-09-30 |
$10,219 |
2020-06-30 |
$10,217 |
2020-03-31 |
$10,209 |
2019-12-31 |
$10,172 |
2019-09-30 |
$10,168 |
2019-06-30 |
$10,165 |
2019-03-31 |
$10,151 |
2018-12-31 |
$10,121 |
2018-09-30 |
$10,117 |
2018-06-30 |
$10,114 |
2018-03-31 |
$10,103 |
2017-12-31 |
$10,090 |
2017-09-30 |
$10,086 |
2017-06-30 |
$10,085 |
2017-03-31 |
$10,041 |
2016-12-31 |
$10,038 |
2016-09-30 |
$10,034 |
2016-06-30 |
$9,915 |
2016-03-31 |
$9,906 |
2015-12-31 |
$9,897 |
2015-09-30 |
$9,900 |
2015-06-30 |
$9,881 |
2015-03-31 |
$9,810 |
2014-12-31 |
$8,349 |
2014-09-30 |
$8,334 |
2014-06-30 |
$8,326 |
2014-03-31 |
$8,316 |
2013-12-31 |
$8,301 |
2013-09-30 |
$8,260 |
2013-06-30 |
$8,250 |
2013-03-31 |
$5,943 |
2012-12-31 |
$5,941 |
2012-09-30 |
$5,917 |
2012-06-30 |
$5,885 |
2012-03-31 |
$5,937 |
2011-12-31 |
$5,964 |
2011-09-30 |
$5,981 |
2011-06-30 |
$5,873 |
2011-03-31 |
$5,199 |
2010-12-31 |
$5,252 |
2010-09-30 |
$5,190 |
2010-06-30 |
$1,468 |
2010-03-31 |
$1,467 |
2009-12-31 |
$1,465 |
2009-09-30 |
$1,464 |
2009-06-30 |
$1,464 |
2009-03-31 |
$1,464 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Generic Drugs |
$3.009B |
$8.757B |
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
|